Items where authors include "Minton, J"

Article

Relph, KA, Russell, CD, Fairfield, CJ et al. (365 more authors) (2022) Procalcitonin is not a reliable biomarker of bacterial coinfection in people with coronavirus disease 2019 undergoing microbiological investigation at the time of hospital admission. Open Forum Infectious Diseases, 9 (5). ofac179.

Abani, O, Abbas, A, Abbas, F et al. (6300 more authors) (2022) Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial. The Lancet, 399 (10325). pp. 665-676. ISSN 0140-6736

Dejnirattisai, W, Huo, J, Zhou, D et al. (461 more authors) (2022) SARS-CoV-2 Omicron-B.1.1.529 leads to widespread escape from neutralizing antibody responses. Cell, 185 (3). 467-484.e15. ISSN 0092-8674

Sullivan, MK, Lees, JS, Drake, TM et al. (362 more authors) (2022) Acute kidney injury in patients hospitalized with COVID-19 from the ISARIC WHO CCP-UK Study : a prospective, multicentre cohort study. Nephrology Dialysis Transplantation, 37 (2). pp. 271-284. ISSN 0931-0509

Niemi, MEK, Karjalainen, J, Liao, RG et al. (3763 more authors) (2021) Mapping the human genetic architecture of COVID-19. Nature, 600 (7889). pp. 472-477. ISSN 0028-0836

de Silva, TI orcid.org/0000-0002-6498-9212, Liu, G, Lindsey, BB orcid.org/0000-0003-4227-2592 et al. (1010 more authors) (2021) The impact of viral mutations on recognition by SARS-CoV-2 specific T cells. iScience, 24 (11). 103353. ISSN 2589-0042

Wickenhagen, A, Sugrue, E, Lytras, S et al. (420 more authors) (2021) A prenylated dsRNA sensor protects against severe COVID-19. Science, 374 (6567). eabj3624. ISSN 0036-8075

Russell, CD, Fairfield, CJ, Drake, TM et al. (369 more authors) (2021) Co-infections, secondary infections, and antimicrobial use in patients hospitalised with COVID-19 during the first pandemic wave from the ISARIC WHO CCP-UK study : a multicentre, prospective cohort study. The Lancet Microbe, 2 (8). e354-e365.

Drake, TM, Riad, AM, Fairfield, CJ et al. (400 more authors) (2021) Characterisation of in-hospital complications associated with COVID-19 using the ISARIC WHO Clinical Characterisation Protocol UK: a prospective, multicentre cohort study. The Lancet, 398 (10296). pp. 223-237. ISSN 0140-6736

Docherty, AB, Mulholland, RH, Lone, NI et al. (377 more authors) (2021) Changes in in-hospital mortality in the first wave of COVID-19: a multicentre prospective observational cohort study using the WHO Clinical Characterisation Protocol UK. The Lancet Respiratory Medicine, 9 (7). pp. 773-785. ISSN 2213-2600

Drake, TM, Fairfield, CJ, Pius, R et al. (359 more authors) (2021) Non-steroidal anti-inflammatory drug use and outcomes of COVID-19 in the ISARIC Clinical Characterisation Protocol UK cohort: a matched, prospective cohort study. The Lancet Rheumatology, 3 (7). e498-e506. ISSN 2665-9913

Bloom, CI, Drake, TM, Docherty, AB et al. (340 more authors) (2021) Risk of adverse outcomes in patients with underlying respiratory conditions admitted to hospital with COVID-19 : a national, multicentre prospective cohort study using the ISARIC WHO Clinical Characterisation Protocol UK. The Lancet Respiratory Medicine, 9 (7). pp. 699-711. ISSN 2213-2600

Leclerc, QJ, Fuller, NM, Keogh, RH et al. (384 more authors) (2021) Importance of patient bed pathways and length of stay differences in predicting COVID-19 hospital bed occupancy in England. BMC Health Services Research, 21. 566. ISSN 1472-6963

Abani, O, Abbas, A, Abbas, F et al. (4809 more authors) (2021) Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised controlled, open-label, platform trial. The Lancet, 397 (10289). pp. 2049-2059. ISSN 0140-6736

Abani, O orcid.org/0000-0003-2209-9956, Abbas, A, Abbas, F et al. (6346 more authors) (2021) Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial. The Lancet, 397 (10285). pp. 1637-1645. ISSN 0140-6736

Gupta, RK, Harrison, EM, Ho, A et al. (372 more authors) (2021) Development and validation of the ISARIC 4C deterioration model for adults hospitalised with COVID-19: a prospective cohort study. The Lancet Respiratory Medicine, 9 (4). pp. 349-359. ISSN 2213-2600

Drake, TM, Docherty, AB, Harrison, EM et al. (398 more authors) (2020) Outcome of hospitalization for COVID-19 in patients with interstitial lung disease. An international multicenter study. American Journal of Respiratory and Critical Care Medicine, 202 (12). pp. 1656-1665. ISSN 1073-449X

Hess, S orcid.org/0000-0002-3650-2518, Meads, D, Twiddy, M et al. (3 more authors) (2020) Characterising heterogeneity and the role of attitudes in patient preferences: a case study in preferences for outpatient parenteral intravenous antimicrobial therapy (OPAT) services. Journal of Choice Modelling. 100252. ISSN 1755-5345

Melhuish, A, Vargas-Palacios, A orcid.org/0000-0002-6503-0134, Yaziji, N et al. (4 more authors) (2020) Cost evaluation of point-of-care testing for community-acquired influenza in adults presenting to the emergency department. Journal of Clinical Virology, 129. 104533. ISSN 1386-6532

Twiddy, M, Czoski Murray, CJ, Mason, SJ et al. (4 more authors) (2018) A qualitative study of patients’ feedback about Outpatient Parenteral Antimicrobial Therapy (OPAT) services in Northern England: implications for service improvement. BMJ Open, 8 (1). e019099. ISSN 2044-6055

Green, M A, Dorling, D, Minton, J et al. (1 more author) (2017) Could the rise in mortality rates since 2015 be explained by changes in the number of delayed discharges of NHS patients? Journal of epidemiology and community health. pp. 1068-1071. ISSN 1470-2738

Vargas-Palacios, A orcid.org/0000-0002-6503-0134, Meads, D orcid.org/0000-0003-1369-2483, Twiddy, M orcid.org/0000-0002-3794-1598 et al. (6 more authors) (2017) Cost-effectiveness of Outpatient Parenteral Antibiotic Therapy: A Simulation Modelling Approach. Journal of Antimicrobial Chemotherapy, 72 (8). pp. 2392-2400. ISSN 0305-7453

Mitchell, ED orcid.org/0000-0002-2833-1632, Czoski Murray, C, Meads, D orcid.org/0000-0003-1369-2483 et al. (3 more authors) (2017) Clinical and cost-effectiveness, safety and acceptability of community intravenous antibiotic service models: CIVAS systematic review. BMJ Open, 7 (4). e013560.

Czoski Murray, C, Twiddy, M, Meads, D et al. (13 more authors) (2015) Community IntraVenous Antibiotic Study (CIVAS): protocol for an evaluation of patient preferences for and cost-effectiveness of community intravenous antibiotic services. BMJ Open, 5 (8). e008965. ISSN 2044-6055

Monograph

Minton, J, Czoski Murray, C orcid.org/0000-0001-7742-2883, Meads, D orcid.org/0000-0003-1369-2483 et al. (10 more authors) (2017) The Community IntraVenous Antibiotic Study (CIVAS): a mixed methods evaluation of patient preferences for and cost effectiveness of different service models for delivering outpatient parenteral antimicrobial therapy. Report. National Institute for Health Research , Health Services and Delivery Research. ISSN 2050-4349

Norman, P orcid.org/0000-0002-6211-1625, Kemp, T and Minton, J (2016) Antibiotic resistance: estimating the population level distribution of Extended-Spectrum Beta-Lactamases (ESBLs) in West Yorkshire, UK. Working Paper.